SREBP1 suppresses the differentiation and epithelial function of hiPSC-derived endothelial cells by inhibiting the microRNA199b-5p pathway
DOI: 10.1016/j.scr.2021.102174
Authors: Xin Qian; Xiangjiang Guo; Qihong Ni; Han Wang; Meng Ye; Lan Zhang
Step 1: iPSC/ESC maintainance
day 0 ~ 1 (duration missing in database; assumed 1 day)
culture “adherent” human PSC in “mTeSR”. For ECM, use “Matrigel” at “N/A” “N/A”.
Ideally, “PSC” should be obtained at the end of culture.
Step 2: Primitive streak 1
day 1 ~ 4
culture “adherent” human PSC in “DMEM/F12” for “3” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “3” days.
| concentration | unit | |
|---|---|---|
| N2 | — | — |
| B27 | — | — |
| BMP4 | 3.0e-5 | g/l |
| CHIR90021 | 5.0e-6 | mol/l |
Step 3: endothelial 1
day 4 ~ 7
culture “adherent” human PSC in “Human Endothelial Serum-free Medium” for “3” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “3” days.
| concentration | unit | |
|---|---|---|
| DAPT | 1.0e-5 | mol/l |
| VEGF | 5.0e-5 | g/l |
| PlGF | 2.5e-5 | g/l |
| HGF | 4.0e-5 | g/l |
Step 4: endothelial 2
day 7 ~ 8 (duration missing in database; assumed 1 day)
culture “adherent” human EC in “Human Endothelial Serum-free Medium”. For ECM, use “Gelatin” at “0.1” “%”. Medium should contain factors shown in the following table.
| concentration | unit | |
|---|---|---|
| VEGF | 3.0e-5 | g/l |
| FGF | 2.0e-5 | g/l |
Ideally, “EC” should express “PECAM1”, “KDR”, “CD34” at the end of culture.